Matthew Charles Mcmurdo serves as Executive at TITAN PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Matthew Charles Mcmurdo has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 11, 2024 involved receiving (via award) 100,000 shares valued at $0.
Matthew Charles Mcmurdo currently holds 100,000 shares of TITAN PHARMACEUTICALS INC (TTNP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Charles Mcmurdo has been a net neutral trader of TTNP stock. They have purchased $0 and sold $0 worth of shares.
Matthew Charles Mcmurdo's most recent insider trade was on Apr 11, 2024, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 25, 2023 | TTNP | $0 | Award | 16,250 | $N/A | Discretionary |
| Jul 26, 2023 | TTNP | $0 | Award | 50,000 | $N/A | Discretionary |
| Jul 26, 2023 | TTNP | $0 | Award | 50,000 | $N/A | Discretionary |